Bristol-Myers Squibb Co. (BMY) PT Lowered to $61 at UBS

November 29, 2021 3:56 AM EST
Get Alerts BMY Hot Sheet
Price: $75.57 +1.49%

Rating Summary:
    13 Buy, 14 Hold, 4 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 8 | Down: 40 | New: 22
Join SI Premium – FREE
UBS analyst Colin Bristow lowered the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $61.00 (from $66.00) while maintaining a Neutral rating.

You May Also Be Interested In

Related Categories

Analyst PT Change